For: | Jeffrey AW, Huang Y, de Boer WB, Adams LA, MacQuillan G, Speers D, Joseph J, Jeffrey GP. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World J Hepatol 2017; 9(19): 850-856 [PMID: 28740596 DOI: 10.4254/wjh.v9.i19.850] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v9/i19/850.htm |
Number | Citing Articles |
1 |
Dujinthan Jayabalan, Yi Huang, Luis Calzadilla‐Bertot, Leon A. Adams, Wendy Cheng, Simon Hazeldine, Briohny W. Smith, Gerry C. MacQuillan, Michael C. Wallace, George Garas, Gary P. Jeffrey. Natural History and Predictors of Clinical Outcomes in Autoimmune Liver Diseases: A Multicenter Study. Journal of Gastroenterology and Hepatology 2025; 40(3): 731 doi: 10.1111/jgh.16850
|
2 |
Wei Liu, Xiwen Jiang, Yue Liu, Qingsong Ma. Bioinformatics Analysis of Quantitative PCR and Reverse Transcription PCR in Detecting HCV RNA. Current Bioinformatics 2019; 14(5): 400 doi: 10.2174/1574893613666180703103328
|
3 |
Jose Hernandez Roman, Mohammad S. Siddiqui. The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease. Endocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.127
|
4 |
Zhengyi Wang, Yi Huang, Hans Nossent, Jonathan J Chan, Leon A Adams, John Joseph, Wendy Cheng, George Garas, Gerry MacQuillan, Gary P Jeffrey. Hepascore predicts liver outcomes and all‐cause mortality in long‐term methotrexate users: A retrospective cohort study. JGH Open 2020; 4(6): 1211 doi: 10.1002/jgh3.12430
|